Thiazolidinedione-based PI3Kα inhibitors: an analysis of biochemical and virtual screening methods.

Publication Year: 2011

DOI:
10.1002/cmdc.201000467

PMCID:
PMC3187668

PMID:
21360822

Journal Information

Full Title: ChemMedChem

Abbreviation: ChemMedChem

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"experimental data on synthesized compounds is provided in the supporting information pi3k x-ray structures (2rd0 2a5u 2wxl) were obtained from the pdb ( http://www rcsb org )."

Code Sharing
COI Disclosure
Evidence found in paper:

"We would like to thank Dr. David Manallack for his assistance in calculating pKa values. We would also like to thank the Victorian Partnership for Advanced Computing (VPAC) and the Victorian Life Sciences Computation Initiative (VLSCI), which are supported by the Australian Commonwealth and Victorian Governments. This work was funded through National Institutes of Health grants CA43460 and CA62924, the Virginia and D.K. Ludwig Fund for Cancer Research (USA), the Cancer Council Victoria no. 436708 and a National Health and Medical Research Council grant no. 545943 (Australia)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025